Happy Mothers, Healthy Babies
Eczema is a chronic, itchy inflammatory skin disease that affects 15% to 30% of children. About 90% of sufferers developed the condition before the age of five. It is one of the risk factors in the development of airways diseases including asthma, later in life. Over the years, accumulating evidence identified a number of factors that are associated with the increased risk of childhood eczema. One of the notable factors identified recently is the experience of stress in mothers or maternal stress. Due to the high prevalence of eczema among children and the detrimental effect of this disease that affects their quality of life, it is worth taking note that preconception maternal health and wellbeing influences the health of the infant.
Protecting Your Baby From Within
Stress itself is not a disease but is disease causing. It can lead to a breakdown in psychological, body and brain functioning. According to a new study conducted by the Medical Research Council Lifecourse Epidemiology Unit, University of Southampton, women who are under stress before conceiving can increase the risk of eczema in their newborns. Maternal stress can release certain hormones that can impact the baby’s immune response. This could lead to an increased risk in eczema. In this survey, the women were asked to report how stressful they were in their daily lives and more than
one in six women reported that their stress level has taken its toll on their health. The risk of their infants developing atopic eczema at the age of 12 months is 20% higher than other participants in the survey.
The “Barker hypothesis” proposed that prenatal maternal-fetal interactions and fetal programming may be linked to the development of asthma or allergic diseases. Fetal programming suggests that the environment surrounding the fetus during the critical phase in fetal development plays a role in determining its disease risk such as eczema and allergies. In 2013, a study was conducted to further evaluate the association between mothers with gestational diabetes and the development of eczema and allergies in their offspring. The results indicated that babies born to mothers with gestational diabetes had higher prevalence of eczema and were more sensitive to allergens.
Baby born to a diabetic mother is more likely to suffer from diabetes and obesity later in life. A mother’s diabetes status can hurt a baby’s development. Birth defects and miscarriage are more likely to occur in women who had diabetes before pregnancy. The baby may experience high blood sugar, low oxygen levels, low blood iron levels, high blood pressure, enlarged heart, poor nervous system and lung development.
Gestational diabetes not only affects the babies’ development but also increases the vulnerability to emotional upheaval such as depression, anxiety and stress among pregnant women. The transition to motherhood is already a major life-changing event and is also a stressful
condition when it is associated with diabetes. Studies have shown that the prevalence of depressive symptoms, anxiety and stress can be as high as 60% in women with gestational diabetes. Undiagnosed and untreated antenatal depressive and anxiety symptoms in women with gestational diabetes could lead to postpartum depression and anxiety. In addition, women suffering from depressive and anxiety symptoms also increase the risk of eczema in the babies.
The Road To Good Health Is Paved With Good Gut Health
The gut is the home base for the bacteria in our digestive tract. All of us have more bacteria in our body than cells. Most of these bacteria are beneficial to us. They not only help in good digestion but work all over the body for our physical and mental health. A lot of studies have emerged over the years that showed that the balance and imbalance of bacteria in our digestive tract was linked to our overall health and disease. Probiotics have the ability to modulate our gut microbiota composition and lead to a reduction in harmful bacteria while restoring the natural balance of our gut bacteria.
Lactobacillus rhamnosus HN001™ is the first strain of probiotic that is proven to be safe and effective in infants and pregnant mothers. This strain of probiotic may reduce the prevalence of post-natal depression through the gut-brain axis. The gut-brain axis comprises a two-way communication between the gut and
the brain. It links the emotional and cognitive centers of the brain with the gut. Recent advances have demonstrated the importance of gut microbiota in influencing brain health. A randomised controlled trial has demonstrated that supplementing with Lactobacillus rhamnosus HN001™ has shown improvement in psychological outcomes. The number of women with depressed and anxiety symptoms are found to be lower in those taking this strain of probiotic.
More than one out of four women in Malaysia developed gestational diabetes throughout their pregnancy. A total of 745 records were reviewed and the risk of gestational diabetes is higher in women above the age of 35 years old and those who have maternal obesity. Pregnant mothers who start taking Lactobacillus rhamnosus HN001™ strain of probiotics have shown a reduced risk of gestational diabetes. Lactobacillus rhamnosus HN001™ also helped to prevent future episodes of gestational diabetes. The prevalence of gestational diabetes has dropped to 0% in the treatment group who has a previous history of gestational diabetes. The prevalence in the placebo group was as high as 87%.
The benefits of Lactobacillus rhamnosus HN001™ supplementation were also extended to the infants. The gut microbiome is established during the first 2 years and will have an impact on the child’s immunity. This particular strain of probiotics given to mothers during pregnancy will bring some significant benefits for the health of the newborns. Lactobacillus rhamnosus HN001™ is the first early life probiotic that shows positive outcomes for at least the first decade of life across the spectrum of allergic diseases. In one study, infants fed with Lactobacillus rhamnosus HN001™ experienced a 42% lower risk of developing eczema over the first 11 years of life.
Kordel’s Protect Early Life: The Pre- and Post-Natal Probiotic
Kordel’s Protect EarlyLife is a combination of L. acidophilus NCFM® and Lactobacillus rhamnosus HN001™. A woman who experiences a stressful pregnancy or those planning to get pregnant but lead a very stressful lifestyle will benefit from this strain of bacteria. Its benefits are extended to the infants with lower prevalence in eczema development. Pregnant mothers who have a high risk of gestational diabetes or have previous histories of gestational diabetes should be taking this probiotic not only to protect herself from gestational diabetes in her next pregnancy but also the child from developing asthma, allergic diseases, diabetes and obesity later in life. Kordel’s Protect EarlyLife, the one-of-the kind probiotic that is proven safe to mothers and her babies while providing a wide spectrum of benefits to both mother and her newborn.